Evidence map›Paper›PMID 38666980›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Antimicrobial Activity of

Ana Paula Palacios-Rodriguez, Abraham Espinoza-Culupú, Yerson Durán, Tito Sánchez-Rojas

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. International journal of molecular sciences · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Crosstalk between MSC-extracellular vesicles andFrontiers in pharmacology · 2025
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ana Paula Palacios-RodriguezLaboratory of Environmental Microbiology and Biotechnology, Faculty of Biological Sciences, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.ORCID 0000-0003-2687-3208
Abraham Espinoza-CulupúLaboratory of Molecular Microbiology and Biotechnology, Faculty of Biological Sciences, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.ORCID 0000-0002-5553-6385
Yerson DuránLaboratory of Environmental Microbiology and Biotechnology, Faculty of Biological Sciences, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.
Tito Sánchez-RojasLaboratory of Environmental Microbiology and Biotechnology, Faculty of Biological Sciences, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.ORCID 0000-0003-3853-2128
National University of San Marcos · PE

Funding

Postdoctoral fellowship from the CONCYTEC/PROCIENCIA program PE501084176-2023-PROCIENCIAVicerrectorado de Investigación y Posgrado at Universidad Nacional Mayor de San Marcos, B23100881
6 · The paper itself

Abstract

Worldwide, bacterial resistance is one of the most severe public health problems. Currently, the failure of antibiotics to counteract superbugs highlights the need to search for new molecules with antimicrobial potential to combat them. The objective of this research was to evaluate the antimicrobial activity of

Indexed as

antimicrobial activityBacillus amyloliquefaciens BS4broad-spectrum metabolitesculture conditions

Identifiers

PMID38666980
PMCPMC11047741
OpenAlexW4393253933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.